The battle for dominance in China’s digital healthcare sector has entered a new phase, driven by the rapid integration of artificial intelligence.Meituan, the country’s leading local services platform, has officially thrown its hat into the ring with the launch of new AI-powered health products, intensifying competition with established rivals Alibaba Group Holding and JD.com, according to Yicai Global.
On April 14, 2026, Meituan Healthcare unveiled “Xiaotuan Health Assistant” (Xiaotuan Health Butler), an AI-driven tool designed to meet families’ comprehensive health management needs. The launch, coupled with a new paid membership service, signals Meituan’s strategic pivot from simple medicine delivery to holistic, AI-enabled health management.
Meituan’s Family-Centric Strategy
Meituan’s entry into the AI healthcare space is highly targeted. According to Wu Jiani, head of the firm’s instant retail business, the company has identified a surging demand for out-of-hospital daily health management.
“The growth rate of online pharmacies far exceeds the average, with buyers primarily aged 25 to 40,” Wu noted. Crucially, these consumers are not just buying medications for acute illnesses; their purchases are increasingly centered on nursing supplies, chronic disease treatments, and household medicines.
The Xiaotuan Health Assistant is tailored to this demographic. It provides consultation services, helps users interpret complex medical examination reports, and assists in managing the daily health routines of entire families. By focusing on the family unit and lifestyle scenarios, Meituan is leveraging its massive existing user base—who already rely on the app for food delivery and local services—to build a high-frequency, high-stickiness health ecosystem.
A Three-Way Tech Giant Rivalry
Meituan’s move brings it into direct competition with JD Health and Alibaba Health, both of which have aggressively rolled out their own AI initiatives earlier this year.
JD Health recently upgraded its “AI + Medical Devices” strategy, announcing plans to integrate its smart system, JoyInside, into one million devices within a year. The company has already launched AI-powered continuous glucose monitors and AI-connected ventilators, with a heavy focus on supply chain integration and hardware fulfillment.
Alibaba Health, meanwhile, released “Hydrogen Ion” in January—an AI assistant specifically tailored for doctors. This tool focuses on providing evidence-based support, intelligent search, and literature reading capabilities, emphasizing ecosystem synergy and professional medical assistance.
Zhang Yi, chief executive of iiMedia Research, highlighted the distinct strategies of the three giants. “JD Health focuses on supply chain and drug fulfillment, Alibaba Health emphasizes ecosystem synergy and doctor assistant tools, while Meituan is more focused on penetrating family health and lifestyle scenarios,” Zhang explained.
The Imperative of AI in E-commerce
The aggressive push into AI healthcare by these tech behemoths is not merely about capturing a new market; it is a strategic necessity. As traditional e-commerce traffic growth in China stagnates, companies are desperately seeking new avenues for expansion.
The healthcare sector presents a highly attractive alternative. It is characterized by rigid demand, high user stickiness, high average order values, and frequent repurchase rates. However, simply selling drugs online is no longer sufficient to maintain a competitive edge.
“Firms must use AI to rebuild entry points and business models, creating next-generation competitive barriers relying on their own scenario-specific data,” Zhang stressed.
By deploying AI assistants, these companies are transforming themselves from transactional platforms into indispensable health management partners. The AI tools collect valuable data on user health habits, enabling highly personalized product recommendations and services, thereby locking consumers into their respective ecosystems, a trend that mirrors the broader agentic AI boom in China.
As Meituan, Alibaba, and JD.com continue to deeply cultivate their niches, the Chinese consumer stands to benefit from increasingly sophisticated, accessible, and personalized healthcare services. The race is no longer just about who can deliver medicine the fastest, but who can provide the smartest, most comprehensive health management through the power of artificial intelligence.